Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants

Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants

  • 1. Zambrano RHP, Ellington S., stride p, et al. Update: Characteristics of Symptomatic Women of Reproductive Age With Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status: United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:16411647.

  • two. desist CL, Wallace B., Simeone, et al. Risk of stillbirth among women with and without COVID-19 at hospitalization for delivery: United States, March 2020–September 2021. MMWR Morb Mortal Wkly Rep 2021;70:16401645.

  • 3. aa butt, Chemaitelly H, Al-Khal A., et al. Effectiveness of the SARS-CoV-2 vaccine in preventing confirmed infection in pregnant women. J Clin invest 2021;131(23):e153662e153662.

  • Four. dagan n, fence n, Biron-Shental T, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. NatMed 2021;27:16931695

  • 5. HS lip type, Vazquez-Benitez G, de silva, et al. Receipt of COVID-19 Vaccine During Pregnancy and Premature or Small for Gestational Age at Birth: Eight Integrated Health Care Organizations, United States, December 15, 2020 to July 22, 2021. MMWR Morb Mortal Wkly Rep 2022;71:2630.

  • 6. Shimabukuro TT, kim sy, Myers TR, et al. Preliminary findings on the safety of the mRNA Covid-19 vaccine in pregnant people. N English J Med 2021;384:22732282.

  • 7. Zauche LH, Wallace B., Smoots AN, et al. Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion. N English J Med 2021;385:15331535.

  • 8. Magnus MC, GjessingHK, Eide HN, Wilcox A.J., dropped DB, Håberg SE. Covid-19 vaccination during pregnancy and first trimester miscarriage. N English J Med 2021;385:20082010.

  • 9. Centers for Disease Control and Prevention. COVID-19 vaccines while pregnant or breastfeeding (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html).

  • 10 Abu Raya B, Edwards KM, Scheifele D.W., Halperin SA. Immunization against pertussis and influenza during pregnancy: a review of the landscape. Lancet Infect Dis 2017;17(7):e209e222.

  • eleven Azziz-Baumgartner E, Grohskopf L, Patel M. Realize the potential of maternal influenza vaccination. JAMA 2021;325:22572259.

  • 12 Omer SB. Maternal immunization. N English J Med 2017;376:12561267.

  • 13 Halase NB, Olson SM, MA State, et al. Effectiveness of maternal vaccination with COVID-19 mRNA vaccine during pregnancy against COVID-19-associated hospitalization in infants younger than 6 months — 17 states, July 2021 to January 2022. MMWR Morb Mortal Wkly Rep 2022;71:264270.

  • 14 Carlsen United States, Magnus MC, Oakley L, et al. Association of vaccination against COVID-19 during pregnancy with the incidence of SARS-CoV-2 infection in infants. JAMA Intern Med 2022 June 1 (Epub before print).

  • fifteen. Mithal LB, Knoll, Shanes ED, Goldstein J.A., Miller EN. Cord blood antibodies after maternal vaccination against coronavirus disease 2019 during pregnancy. Am J Obstet Gynecol 2021;225:192194.

  • sixteen. Beharier O, Plitman Mayo R., once you, et al. Efficient transfer of maternal-neonatal antibodies against SARS-CoV-2 and the BNT162b2 mRNA COVID-19 vaccine. J Clin invest 2021;131:150319150319.

  • 17 Prabhu M, Murphy EA, A.C. Sukhu, et al. Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage to umbilical cord blood. obstetrics gynecology 2021;138:278280.

  • 18 Perl SH, Uzan-Yulzari A, klainerh, et al. SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of lactating women. JAMA 2021;325:20132014.

  • 19 Baird JK, Jensen SM, Urban WJ, BA fox, Baird JR. Antibodies against SARS-CoV-2 detected in breast milk after vaccination. J hum lacto 2021;37:492498.

  • twenty Yang YJ |, Murphy EA, Singh S., et al. Association of gestational age at the time of coronavirus disease 2019 (COVID-19) vaccination, history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a booster dose of the vaccine with Maternal and umbilical cord antibody levels at delivery. obstetrics gynecology 2022;139:373380.

  • twenty-one trot me, Aguero-Rosenfeld ME, roman like, JL lighter. High levels of antibodies in cord blood of pregnant women vaccinated against COVID-19. I’m J Obstet Gynecol MFM 2021;3:100481100481.

  • 22 Nir O, Schwartz A., Toussia-Cohen S, et al. Maternal-neonatal transfer of immunoglobulin G antibodies against SARS-CoV-2 among parturient women treated with the messenger RNA vaccine BNT162b2 during pregnancy. I’m J Obstet Gynecol MFM 2022;4:100492100492.

  • 23 shook LL, Atyeo CG, Yonker LM, et al. Durability of spike antibodies in infants after maternal vaccination against COVID-19 or natural infection. JAMA 2022;327:10871089.

  • 24 KJ Brands, Whitaker M, Agathis NT, et al. Hospitalization of Infants and Children Ages 0-4 Years With Laboratory-Confirmed COVID-19: COVID-NET, 14 States, March 2020-February 2022. MMWR Morb Mortal Wkly Rep 2022;71:429436.

  • 25 hobbs resume, Woodworth K., dc young, et al. Frequency, characteristics and complications of COVID-19 in hospitalized infants. Pediatr Infect Dis J 2022;41(3):e81e86.

  • 26 Mølgaard-Nielsen D, Fischer’s TK, Krause TG, Hviid A. Effectiveness of maternal immunization with trivalent inactivated influenza vaccine in pregnant women and their infants. J Intern Med 2019;286:469480.

  • 27 Olson SM, Newhams MM, Halase NB, et al. Vaccine Effectiveness Against Life-threatening Influenza Illness in US Children Clin Infect Dis 2022 January 13 (Epub before print).

  • 28 bitter friends, feng s, Lewnard JA, et al. The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology. Epidemiology 2020;31:4364.

  • 29 Olson SM, Newhams MM, Halase NB, et al. Effectiveness of the BNT162b2 vaccine against Critical Covid-19 in adolescents. N English J Med 2022;386:713723.

  • 30 Olson SM, Newhams MM, Halase NB, et al. Efficacy of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons 12 to 18 Years of Age: United States, June to September 2021. MMWR Morb Mortal Wkly Rep 2021;70:14831488.

  • 31 Federal Register Office. Code of Federal Regulations: A point in time of the eCFR system. Title 45 (https://www.ecfr.gov/cgi-bin/text-idx?SID=fc043bd2812f0775fa80066558a6bbcf&mc=true&node=pt45.1.46&rgn=div5#se45.1.46_1102).

  • 32. Razzaghi H., Megan M, Pingali C, et al. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy: Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021. MMWR Morb Mortal Wkly Rep 2021;70:895899.

  • 33. Patel MK, Bergeri I, Bresee JS, et al. Post-introduction evaluation of COVID-19 vaccine efficacy: summary of interim guidance from the World Health Organization. Vaccine 2021;39:40134024.

  • 3. 4. Centers for Disease Control and Prevention. COVID Data Tracker: Variant Proportions (https://covid.cdc.gov/covid-data-tracker/#variant-proportions).

  • 35. KJ gray, Bordt EA, atyeo c, et al. Response to coronavirus disease 2019 vaccine in pregnant and lactating women: a cohort study. Am J Obstet Gynecol 2021;225(3):303.e1303.e17.

  • 36. Klein National Park, MS Stockwell, Demarco M, et al. Effectiveness of Pfizer-BioNTech BNT162b2 mRNA vaccination against COVID-19 in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among non-immunocompromised children and adolescents aged 5 to 17 years. age: VISION Network, 10 states, April 2021-January 2022. MMWR Morb Mortal Rep Weekly 2022;71:352358.

  • 37. graduating as, Tenforde MW, Chappell JD, et al. Clinical severity and efficacy of SARS-CoV-2 omicron, delta, and alpha variant Covid-19 mRNA vaccines in the United States: a prospective observational study. BMJ 2022;376:e069761e069761.

  • 38. Centers for Disease Control and Prevention. Cumulative data on file: Percentage of pregnant women ages 18-49 who received at least one dose of a COVID-19 vaccine during pregnancy overall, by race/ethnicity and date reported to CDC-Vaccine Safety Datalink*, United States | December 20, 2020–January 20, 2022 (https://data.cdc.gov/Vaccinations/Cumulative-Data-Percent-of-Pregnant-People-aged-18/4ht3-nbmd/data).

  • 39. nemet me, L button, funny, et al. Third neutralization of the BNT162b2 vaccine from SARS-CoV-2 infection omicron. N English J Med 2022;386:492494.

  • 40 thompsonmg, Natarajan K., Irving SA, et al. Efficacy of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant dominance — VISION Network, 10 states, August 2021–January 2022. MMWR Morb Mortal Wkly Rep 2022;71:139145.

  • Leave a Comment

    Your email address will not be published.